References

Clinical features and disease haplotypes of individuals with the N279K tau gene mutation: A comparison of the pallidopontonigral degeneration kindred and a French family

10.1001/archneur.59.6.943 · ExternalCitation · doi-reference

Exploratory tau biomarker results from a multiple ascending-dose study of BIIB080 in Alzheimer disease: A randomized clinical trial

10.1001/jamaneurol.2023.3861 · ExternalCitation · doi-reference

Design of a phase 2, randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy, safety, and tolerability of BIIB080 in subjects with mild cognitive impairment due to Alzheimer’s disease or mild Alzheimer’s disease dementia

10.1002/alz.077322 · ExternalCitation · doi-reference

Bezafibrate treatment rescues neurodevelopmental and neurodegenerative defects in 3D cortical organoid model of MAPT frontotemporal dementia

10.1002/alz.70419 · ExternalCitation · doi-reference

Functional selection of tau oligomerization-inhibiting aptamers

10.1002/anie.202402007 · ExternalCitation · doi-reference

Bottom-up design of small molecules that stimulate exon 10 skipping in mutant MAPT pre-mRNA

10.1002/cbic.201402069 · ExternalCitation · doi-reference

Expression of embryonic tau protein isoforms persist during adult neurogenesis in the hippocampus

10.1002/hipo.20255 · ExternalCitation · doi-reference

Minigenes to confirm exon skipping mutations

10.1007/978-1-61779-767-5_3 · ExternalCitation · doi-reference

A new non-aggregative splicing isoform of human Tau is decreased in Alzheimer’s disease

10.1007/s00401-021-02317-z · ExternalCitation · doi-reference

Dysregulated coordination of MAPT exon 2 and exon 10 splicing underlies different tau pathologies in PSP and AD

10.1007/s00401-021-02392-2 · ExternalCitation · doi-reference

Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick’s disease, corticobasal degeneration and progressive supranuclear palsy

10.1007/s004010000283 · ExternalCitation · doi-reference

Familial frontotemporal dementia and parkinsonism with a novel N296H mutation in exon 10 of the tau gene and a widespread tau accumulation in the glial cells

10.1007/s004010000333 · ExternalCitation · doi-reference

Givosiran: First approval

10.1007/s40265-020-01269-0 · ExternalCitation · doi-reference

Lumasiran: First approval

10.1007/s40265-020-01463-0 · ExternalCitation · doi-reference

Developmentally regulated expression of specific tau sequences

10.1016/0896-6273(89)90077-9 · ExternalCitation · doi-reference

Multiple isoforms of human microtubule-associated protein tau: Sequences and localization in neurofibrillary tangles of Alzheimer’s disease

10.1016/0896-6273(89)90210-9 · ExternalCitation · doi-reference

Development of an oral treatment that rescues gait ataxia and retinal degeneration in a phenotypic mouse model of familial dysautonomia

10.1016/j.ajhg.2023.01.019 · ExternalCitation · doi-reference

Neurodegenerative disorder FTDP-17-related tau intron 10 +16C\>T mutation increases tau exon 10 splicing and causes tauopathy in transgenic mice

10.1016/j.ajpath.2013.03.015 · ExternalCitation · doi-reference

Tau gene alternative splicing: Expression patterns, regulation and modulation of function in development and disease

10.1016/j.bbadis.2004.08.010 · ExternalCitation · doi-reference

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

10.1016/j.cell.2007.11.019 · ExternalCitation · doi-reference

ELAVL4, splicing, and glutamatergic dysfunction precede neuron loss in MAPT mutation cerebral organoids

10.1016/j.cell.2021.07.003 · ExternalCitation · doi-reference

Altered tau isoform ratio caused by loss of FUS and SFPQ function leads to FTLD-like phenotypes

10.1016/j.celrep.2017.01.013 · ExternalCitation · doi-reference

Transgenic mice expressing mutant (N279K) human tau show mutation dependent cognitive deficits without neurofibrillary tangle formation

10.1016/j.febslet.2005.09.047 · ExternalCitation · doi-reference

Human organotypic brain slice cultures: A detailed and improved protocol for preparation and long-term maintenance

10.1016/j.jneumeth.2023.110055 · ExternalCitation · doi-reference

Alternative splicing in Alzheimer’s disease: Driver, modifier, or consequence of neurodegeneration

10.1016/j.mad.2026.112211 · ExternalCitation · doi-reference

Small molecule modulators of pre-mRNA splicing in cancer therapy

10.1016/j.molmed.2015.11.005 · ExternalCitation · doi-reference

Three ‘E’ challenges for siRNA drug development

10.1016/j.molmed.2023.10.005 · ExternalCitation · doi-reference

Differentiated NSC-34 motoneuron-like cells as experimental model for cholinergic neurodegeneration

10.1016/j.neuint.2013.03.008 · ExternalCitation · doi-reference

Targeting tau: Clinical trials and novel therapeutic approaches

10.1016/j.neulet.2020.134919 · ExternalCitation · doi-reference

A clinical, molecular genetics and pathological study of a FTDP-17 family with a heterozygous splicing variant c.823-10G\>T at the intron 9/exon 10 of the MAPT gene

10.1016/j.neurobiolaging.2021.05.010 · ExternalCitation · doi-reference

Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the phase 2 NURTURE study

10.1016/j.nmd.2019.09.007 · ExternalCitation · doi-reference

Development, opportunities, and challenges of siRNA nucleic acid drugs

10.1016/j.omtn.2024.102437 · ExternalCitation · doi-reference

Correcting tau isoform ratios with a long-acting antisense oligonucleotide alleviates 4R-tauopathy phenotypes

10.1016/j.omtn.2025.102503 · ExternalCitation · doi-reference

Prime editing corrects the dilated cardiomyopathy causing RBM20-P633L-mutation in human cardiomyocytes

10.1016/j.omtn.2025.102734 · ExternalCitation · doi-reference

Detection of all adult Tau isoforms in a 3D culture model of iPSC-derived neurons

10.1016/j.scr.2019.101541 · ExternalCitation · doi-reference

Distinct neurodegenerative changes in an induced pluripotent stem cell model of frontotemporal dementia linked to mutant TAU protein

10.1016/j.stemcr.2015.06.001 · ExternalCitation · doi-reference

Genetically engineered iPSC-derived FTDP-17 MAPT neurons display mutation-specific neurodegenerative and neurodevelopmental phenotypes

10.1016/j.stemcr.2018.06.022 · ExternalCitation · doi-reference

Lineage-specific splicing regulation of MAPT gene in the primate brain

10.1016/j.xgen.2024.100563 · ExternalCitation · doi-reference

Use of minigene systems to dissect alternative splicing elements

10.1016/j.ymeth.2005.07.015 · ExternalCitation · doi-reference

RNA stimulates aggregation of microtubule-associated protein tau into Alzheimer-like paired helical filaments

10.1016/s0014-5793(96)01386-5 · ExternalCitation · doi-reference

FTDP-17 mutations N279K and S305N in tau produce increased splicing of exon 10

10.1016/s0014-5793(98)01696-2 · ExternalCitation · doi-reference

Tau protein isoforms, phosphorylation and role in neurodegenerative disorders

10.1016/s0165-0173(00)00019-9 · ExternalCitation · doi-reference

The in vivo minigene approach to analyze tissue-specific splicing

10.1016/s1385-299x(99)00043-4 · ExternalCitation · doi-reference

Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer’s disease and frontotemporal lobar degeneration: A retrospective diagnostic performance study

10.1016/s1474-4422(21)00214-3 · ExternalCitation · doi-reference

Discovery of risdiplam, a selective survival of motor neuron-2 (SMN2) gene splicing modifier for the treatment of spinal muscular atrophy (SMA)

10.1021/acs.jmedchem.8b00741 · ExternalCitation · doi-reference

Inhibitory RNA aptamers of tau oligomerization and their neuroprotective roles against proteotoxic stress

10.1021/acs.molpharmaceut.6b00165 · ExternalCitation · doi-reference

Design of an orally bioavailable small molecule that modulates the microtubule-associated protein tau’s pre-mRNA splicing

10.1021/acschembio.5c00260 · ExternalCitation · doi-reference

Structure and novel exons of the human tau gene

10.1021/bi00158a027 · ExternalCitation · doi-reference

Design, optimization, and study of small molecules that target tau pre-mRNA and affect splicing

10.1021/jacs.0c00768 · ExternalCitation · doi-reference

Association of missense and 5’-splice-site mutations in tau with the inherited dementia FTDP-17

10.1038/31508 · ExternalCitation · doi-reference

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

10.1038/35888 · ExternalCitation · doi-reference

Spliceosome-mediated RNA trans-splicing as a tool for gene therapy

10.1038/6986 · ExternalCitation · doi-reference

Neurofibrillary tangles, amyotrophy, and progressive motor disturbance in mice expressing a mutant (P301L) tau protein

10.1038/78078 · ExternalCitation · doi-reference

Antisense-mediated exon skipping decreases tau protein expression: A potential therapy for tauopathies

10.1038/mtna.2014.30 · ExternalCitation · doi-reference

Cerebral organoids model human brain development and microcephaly

10.1038/nature12517 · ExternalCitation · doi-reference

Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage

10.1038/nature17946 · ExternalCitation · doi-reference

Cell diversity and network dynamics in photosensitive human brain organoids

10.1038/nature22047 · ExternalCitation · doi-reference

Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage

10.1038/nature24644 · ExternalCitation · doi-reference

The chemical evolution of oligonucleotide therapies of clinical utility

10.1038/nbt.3765 · ExternalCitation · doi-reference

SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice

10.1038/nchembio.1837 · ExternalCitation · doi-reference

Pre-mRNA splicing in disease and therapeutics

10.1038/nrg.2015.3 · ExternalCitation · doi-reference

Tau in physiology and pathology

10.1038/nrn.2015.1 · ExternalCitation · doi-reference

Therapeutic siRNA: State of the art

10.1038/s41392-020-0207-x · ExternalCitation · doi-reference

Genetically engineered MAPT 10+16 mutation causes pathophysiological excitability of human iPSC-derived neurons related to 4R tau-induced dementia

10.1038/s41419-021-04007-w · ExternalCitation · doi-reference

Blood–brain barrier opening in Alzheimer’s disease using MR-guided focused ultrasound

10.1038/s41467-018-04529-6 · ExternalCitation · doi-reference

A deep learning approach to identify gene targets of a therapeutic for human splicing disorders

10.1038/s41467-021-23663-2 · ExternalCitation · doi-reference

Systematic optimization of prime editing for the efficient functional correction of CFTR F508del in human airway epithelial cells

10.1038/s41551-024-01233-3 · ExternalCitation · doi-reference

10.1038/s41551-026-01747-y

10.1038/s41551-026-01747-y · ExternalCitation · doi-reference

Cellular and pathological functions of tau

10.1038/s41580-024-00753-9 · ExternalCitation · doi-reference

Search-and-replace genome editing without double-strand breaks or donor DNA

10.1038/s41586-019-1711-4 · ExternalCitation · doi-reference

Efficient prime editing in mouse brain, liver and heart with dual AAVs

10.1038/s41587-023-01758-z · ExternalCitation · doi-reference

Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: A phase 1b, randomized, placebo-controlled trial

10.1038/s41591-023-02326-3 · ExternalCitation · doi-reference

Human ALS/FTD brain organoid slice cultures display distinct early astrocyte and targetable neuronal pathology

10.1038/s41593-021-00923-4 · ExternalCitation · doi-reference

Ultrasound-mediated blood–brain barrier opening enhances delivery of therapeutically relevant formats of a tau-specific antibody

10.1038/s41598-019-45577-2 · ExternalCitation · doi-reference

Optimised techniques for high-throughput screening of differentiated SH-SY5Y cells and application for neurite outgrowth assays

10.1038/s41598-021-03442-1 · ExternalCitation · doi-reference

Exploratory analyses of clinical outcomes from the BIIB080 phase 1b study in mild Alzheimer’s disease

10.1038/s43587-025-01031-9 · ExternalCitation · doi-reference

Calcium dysregulation contributes to neurodegeneration in FTLD patient iPSC-derived neurons

10.1038/srep34904 · ExternalCitation · doi-reference

Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms (htau mice)

10.1046/j.1471-4159.2003.01879.x · ExternalCitation · doi-reference

Tau exon 10, whose missplicing causes frontotemporal dementia, is regulated by an intricate interplay of cis elements and trans factors

10.1046/j.1471-4159.2003.02232.x · ExternalCitation · doi-reference

Nusinersen versus sham control in infantile-onset spinal muscular atrophy

10.1056/nejmoa1702752 · ExternalCitation · doi-reference

Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis

10.1056/nejmoa1716153 · ExternalCitation · doi-reference

Reprogramming of tau alternative splicing by spliceosome-mediated RNA trans-splicing: Implications for tauopathies

10.1073/pnas.0503150102 · ExternalCitation · doi-reference

A high-throughput screening strategy identifies cardiotonic steroids as alternative splicing modulators

10.1073/pnas.0801661105 · ExternalCitation · doi-reference

Allele-specific silencing of dominant disease genes

10.1073/pnas.1231012100 · ExternalCitation · doi-reference

Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor

10.1073/pnas.73.7.2424 · ExternalCitation · doi-reference

Mutation in the tau gene in familial multiple system tauopathy with presenile dementia

10.1073/pnas.95.13.7737 · ExternalCitation · doi-reference

Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements

10.1073/pnas.96.10.5598 · ExternalCitation · doi-reference

5’ splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon 10

10.1074/jbc.274.21.15134 · ExternalCitation · doi-reference

Structural and functional differences between 3-repeat and 4-repeat tau isoforms

10.1074/jbc.m007489200 · ExternalCitation · doi-reference

Correction of alternative splicing of tau in frontotemporal dementia and parkinsonism linked to chromosome 17

10.1074/jbc.m105113200 · ExternalCitation · doi-reference

Mutations in tau gene exon 10 associated with FTDP-17 alter the activity of an exonic splicing enhancer to interact with Tra2 beta

10.1074/jbc.m301800200 · ExternalCitation · doi-reference

Exon-skipping antisense oligonucleotides to correct missplicing in neurogenetic diseases

10.1089/nat.2013.0461 · ExternalCitation · doi-reference

Inherited frontotemporal dementia in nine British families associated with intronic mutations in the tau gene

10.1093/brain/awf069 · ExternalCitation · doi-reference

Early maturation and distinct tau pathology in induced pluripotent stem cell-derived neurons from patients with MAPT mutations

10.1093/brain/awv222 · ExternalCitation · doi-reference

Inclisiran: A new milestone on the PCSK9 road to tackle cardiovascular risk

10.1093/ehjcvp/pvab014 · ExternalCitation · doi-reference

Correction of tau mis-splicing caused by FTDP-17 MAPT mutations by spliceosome-mediated RNA trans-splicing

10.1093/hmg/ddp264 · ExternalCitation · doi-reference

Trans-splicing correction of tau isoform imbalance in a mouse model of tau mis-splicing

10.1093/hmg/ddt108 · ExternalCitation · doi-reference

Developmental regulation of tau splicing is disrupted in stem cell-derived neurons from frontotemporal dementia patients with the 10+16 splice-site mutation in MAPT

10.1093/hmg/ddv246 · ExternalCitation · doi-reference

Structural basis for recognition of the RNA major groove in the tau exon 10 splicing regulatory element by aminoglycoside antibiotics

10.1093/nar/28.3.710 · ExternalCitation · doi-reference

Targeting Alzheimer’s disease genes with RNA interference: An efficient strategy for silencing mutant alleles

10.1093/nar/gkh208 · ExternalCitation · doi-reference

Pro-apoptotic effects of tau mutations in chromosome 17 frontotemporal dementia and parkinsonism

10.1097/00001756-200001170-00011 · ExternalCitation · doi-reference

Preliminary safety and tolerability of a novel subcutaneous intrathecal catheter system for repeated outpatient dosing of nusinersen to children and adults with spinal muscular atrophy

10.1097/bpo.0000000000001247 · ExternalCitation · doi-reference

Delivery of nusinersen through an Ommaya reservoir in spinal muscular atrophy

10.1097/cnd.0000000000000333 · ExternalCitation · doi-reference

10.1101/2024.06.02.597022

10.1101/2024.06.02.597022 · ExternalCitation · doi-reference

A minimal length between tau exon 10 and 11 is required for correct splicing of exon 10

10.1111/j.1471-4159.2004.02477.x · ExternalCitation · doi-reference

The alternative splicing of tau exon 10 and its regulatory proteins CLK2 and TRA2-BETA1 changes in sporadic Alzheimer’s disease

10.1111/j.1471-4159.2005.03552.x · ExternalCitation · doi-reference

Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick’s disease

10.1111/j.1750-3639.1999.tb00550.x · ExternalCitation · doi-reference

Small molecule targeting of RNA structures in neurological disorders

10.1111/nyas.14051 · ExternalCitation · doi-reference

The growing class of novel RNAi therapeutics

10.1124/molpharm.124.000895 · ExternalCitation · doi-reference

Tau suppression in a neurodegenerative mouse model improves memory function

10.1126/science.1113694 · ExternalCitation · doi-reference

A century of Alzheimer’s disease and tau pathology

10.1126/science.1132814 · ExternalCitation · doi-reference

Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17

10.1126/science.282.5395.1914 · ExternalCitation · doi-reference

Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy

10.1126/scitranslmed.aag0481 · ExternalCitation · doi-reference

MAPT splicing modulators reduce 4R tau and rescue tauopathy phenotypes in human neurons and in a mouse model

10.1126/scitranslmed.ady6759 · ExternalCitation · doi-reference

Aberrant splicing of tau pre-mRNA caused by intronic mutations associated with the inherited dementia frontotemporal dementia with parkinsonism linked to chromosome 17

10.1128/mcb.20.11.4036-4048.2000 · ExternalCitation · doi-reference

Pharmacology of antisense drugs

10.1146/annurev-pharmtox-010716-104846 · ExternalCitation · doi-reference

10.1186/1471-2202-8-36

10.1186/1471-2202-8-36 · ExternalCitation · doi-reference

Tau exon 10 alternative splicing and tauopathies

10.1186/1750-1326-3-8 · ExternalCitation · doi-reference

Frontotemporal dementia-associated N279K tau mutant disrupts subcellular vesicle trafficking and induces cellular stress in iPSC-derived neural stem cells

10.1186/s13024-015-0042-7 · ExternalCitation · doi-reference

The SH-SY5Y cell line in Parkinson’s disease research: A systematic review

10.1186/s13024-017-0149-0 · ExternalCitation · doi-reference

Human post-mortem organotypic brain slice cultures: A tool to study pathomechanisms and test therapies

10.1186/s40478-024-01784-1 · ExternalCitation · doi-reference

Clinical and genetic studies of families with the tau N279K mutation (FTDP-17)

10.1212/01.wnl.0000038909.49164.4b · ExternalCitation · doi-reference

10.1371/journal.pgen.0030109

10.1371/journal.pgen.0030109 · ExternalCitation · doi-reference

Antisense reduction of tau in adult mice protects against seizures

10.1523/jneurosci.2107-13.2013 · ExternalCitation · doi-reference

The tau N279K exon 10 splicing mutation recapitulates frontotemporal dementia and parkinsonism linked to chromosome 17 tauopathy in a mouse model

10.1523/jneurosci.5492-06.2007 · ExternalCitation · doi-reference

Delivery of oligonucleotide-based therapeutics: Challenges and opportunities

10.15252/emmm.202013243 · ExternalCitation · doi-reference

10.20944/preprints202306.1818.v1

10.20944/preprints202306.1818.v1 · ExternalCitation · doi-reference

Brain drug delivery: Overcoming the blood-brain barrier to treat tauopathies

10.2174/1381612826666200316130128 · ExternalCitation · doi-reference

Tau silencing by siRNA in the P301S mouse model of tauopathy

10.2174/156652321405140926160602 · ExternalCitation · doi-reference

Human brain slice cultures: Translational applications and ethical considerations

10.26508/lsa.202403160 · ExternalCitation · doi-reference

An in vitro model for neuroscience: Differentiation of SH-SY5Y cells into cells with morphological and biochemical characteristics of mature neurons

10.3233/jad-2010-091363 · ExternalCitation · doi-reference

10.3389/fbioe.2022.951384

10.3389/fbioe.2022.951384 · ExternalCitation · doi-reference

10.3389/fmolb.2025.1750807

10.3389/fmolb.2025.1750807 · ExternalCitation · doi-reference

10.3389/fnagi.2020.00011

10.3389/fnagi.2020.00011 · ExternalCitation · doi-reference

10.3389/fncel.2018.00202

10.3389/fncel.2018.00202 · ExternalCitation · doi-reference

10.3389/fnins.2022.838594

10.3389/fnins.2022.838594 · ExternalCitation · doi-reference

10.3389/fphar.2022.974666

10.3389/fphar.2022.974666 · ExternalCitation · doi-reference

10.3390/biomedicines13092167

10.3390/biomedicines13092167 · ExternalCitation · doi-reference

10.3390/ijms232315383

10.3390/ijms232315383 · ExternalCitation · doi-reference

10.3390/molecules26082263

10.3390/molecules26082263 · ExternalCitation · doi-reference

10.3390/ph19010164

10.3390/ph19010164 · ExternalCitation · doi-reference

Antisense oligonucleotides provide optimism to the therapeutic landscape for tauopathies

10.4103/nrr.nrr-d-23-02057 · ExternalCitation · doi-reference

Targeted degradation of aberrant tau in frontotemporal dementia patient-derived neuronal cell models

10.7554/elife.45457 · ExternalCitation · doi-reference